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Abstract
 .Binding of two long wavelength fluorescent cAMP analogues, 8-thioacetamido-fluorescein-cAMP SAF-cAMP and
 .  .  .8-thioacetamido-rhodamine-cAMP SAR-cAMP , to the RI from bovine muscle and RII from bovine heart regulatory
w3 xsubunits of cAMP dependent kinases has been studied. Displacement of H cAMP from RI and RII and equilibrium
dialysis measurements show that the fluorescent nucleotides are high affinity ligands for the cAMP binding sites. The
binding is characterized by complex fluorescence spectral and fluorescence anisotropy changes, more evident for the
fluorescein than for the rhodamine derivative. The fluorescence excitation spectrum of the bound SAF-cAMP is
characterized by the appearance of a red shifted shoulder at 500–510 nm excitation wavelength region. Any change of the
boundrfree ratio in a solution equilibrium is accompanied by changes in fluorescence and anisotropy signals which are best
detected at suitable wavelengths. It is proposed that fluorescence and anisotropy changes can distinguish between binding to
 .  .type B slow dissociating and A fast dissociating cAMP binding sites of regulatory subunits. Applications of the
fluorescent nucleotides to kinase localization and cAMP determination in living cells are discussed.
Keywords: cAMP; Fluorescence spectroscopy
1. Introduction
Cyclic AMP-dependent protein kinases are thought
to mediate most biological effects of cAMP. The
holoenzyme is a tetramer comprised of two regula-
tory and two catalytic subunits. Regulatory and cat-
alytic subunits are distinguished in different subtypes
 .Abbreviations: SAF-cAMP, 8- 5-thioacetamidofluorescein -
X X adenosine 3 :5 cyclic monophosphate; SAR-cAMP, 8- 5-thioa-
. X Xcetamidotetramethylrhodamine -adenosine 3 :5 cyclic
monophosphate; RI, cAMP-dependent protein kinase regulatory
subunit type I; RII, regulatory subunit type II
)  .Corresponding author. Fax: 39-521 291304; E-mail: cmu-
cignat@psibo.unibo.it
 w x.for a review see 1 . cAMP binds to the regulatory
subunits, which are by far the most abundant intra-
cellular receptors for cAMP. In every regulatory sub-
unit, two classes of cAMP binding sites, site A, or
fast dissociating, and site B, or slow dissociating
w x2,3 , are present. Their binding parameters for cAMP
are different, although the amino acid sequence and
calculated structure are similar and highly conserved
w xamong the different subtypes 4,5 . Upon binding of
cAMP to the regulatory subunits, the catalytic sub-
units are released and can phosphorylate their target
proteins. The intracellular distribution of cAMP bind-
ing sites is not homogeneous: both biochemical and
immunohistochemical observations suggest that
cAMP binding sites are segregated in restricted intra-
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cellular domains, presumably through binding to
w xcytoskeletal anchoring proteins 6–9 . The intra-
cellular localization of cAMP dependent kinases is
thought to play an important role in regulating their
activity, by positioning the phosphorylating enzymes
close to their target proteins. In previous papers the
synthesis of fluorescein conjugated cyclic nucleotides
8-thioacetamidofluorescein-cGMP, SAF-cGMP, and
.8-thioacetamidofluorescein-cAMP, SAF-cAMP has
w xbeen reported 10,11 . SAF-cGMP can specifically
bind and visualize the cGMP gated ion channel in
w xvertebrate photoreceptors 11 . In neuronal cells,
SAF-cAMP can visualize aggregates of insoluble
w xconcentrated cAMP binding sites 12 . Since long
wavelength fluorescent nucleotides can be useful in
detecting intracellular distribution of cAMP binding
sites and measuring their concentration, the binding
parameters of two long wavelength fluorescent
derivatives of cAMP SAF-cAMP and 8-thioace-
.tamidorhodamine cAMP, SAR-cAMP to the bio-
chemically well characterized regulatory subunits of
the cAMP dependent kinases are described in this
paper.
2. Materials and methods
2.1. Materials
Thioacetamidofluorescein-cAMP and thioacetami-
dorhodamine-cAMP were either synthesized as previ-
w xously described 11 or obtained from Molecular
Probes.
Sepharose cAMP was from Sigma, Sephadex G
200 from Pharmacia, DE52 from Whatman,
w3 xH cAMP from Amersham.
2.2. Kinase purification
cAMP dependent kinase regulatory subunits RI
.and RII were purified from bovine skeletal muscle
and from bovine heart respectively. Preparation was
according to standard procedures: briefly, fresh tissue
was homogenized in a 5=volume of phosphate buffer
10 mM, pH adjusted to 6.8, with 1 mM EDTA and in
the presence of protease inhibitors Soybean Trypsin
.inhibitor, 0.1 mgrml, PMSF 1 mM . The suspension
was centrifuged at 10 000=g for 30 min on a Sor-
vall SS 34 rotor at 48C. The supernatant was paper
filtered and chromatographed by gel filtration Seph-
.adex G200 . The cAMP binding fractions were
rechromatographed by anion exchange DE52 col-
.umn and eluted with a 10–400 mM NaCl gradient in
10 mM phosphate buffer, pH 6.8. The cAMP binding
fractions were affinity-chromatographed on a 1 ml
Sepharose cAMP column. After washing three times
with 10 ml 2 M NaCl in 10 mM phosphate buffer pH
6.8, then with 10 ml phosphate buffer, and 4 ml 10
mM AMP in phosphate buffer, the regulatory subunit
was eluted with 3 ml 10 mM cAMP in phosphate
buffer. In order to remove bound cAMP from the
protein, it was applied to a DE52 column, washed
with 10 ml 2 mM cGMP in 5 mM phosphate buffer
pH 6.8, at 2 mlrhour, then with 200 ml 5 mM
w xphosphate buffer at 10 mlrhour 13 . The protein was
then eluted with a 10–350 mM NaCl gradient and
centrifuged at 250 000=g for 1 h at 48C on a
Beckman SW 60 rotor. SDS PAGE electrophoresis of
the final eluate showed only one band on the gel.
Protein concentrations are expressed as monomer
concentration.
[3 ]2.3. H cAMP binding experiments
w3 xH cAMP binding and displacement experiments
were performed by filtration, using the ammonium
w xsulfate precipitation procedure 14 . Incubation was at
188C for 30 min, in NaCl 150 mM, phosphate buffer
 .20 mM, pH 7.4. Kinase concentration 1 nM was
adjusted so that at the lowest cAMP concentration,
less than 10% of the nucleotide was bound.
2.4. Dialysis experiments
w3 xSAF-cAMP and H cAMP binding were studied
also by equilibrium dialysis. Aliquots of protein solu-
 .tions 1.5 ml, 250 nM RI or RII were equilibrated in
 .cellulose dialysis bags m.w. cutoff 10 000 with
w3 xSAF-cAMP or H cAMP in 20 ml of 20 mM phos-
phate buffer pH 7.7, 150 mM NaCl. The concentra-
w3 xtion of SAF-cAMP and H cAMP ranged from 2 nM
to 1200 nM for different samples. After 36 h at 188C,
1.2 ml samples were collected from protein solution
in the dialysis bag and from the equilibrating solu-
tion.
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Aspecific binding was measured in parallel sam-
ples in the presence of 100 mM unlabelled cAMP.
Fluorescence spectra and anisotropy measurements
were recorded from all the samples.
In order to dissociate SAF-cAMP from the regula-
tory subunits, and to eliminate the spectral changes
dependent on SAF-cAMP binding to regulatory sub-
 .units see Section 3 , fluorescence intensity of the
inner solution of the sample tubes was measured after
addition of unlabelled cAMP 500 mM final concen-
.tration , which by itself did not affect fluorescence of
the free fluorescent nucleotide. At the end of the
experiment, the actual concentration of nucleotide in
the external and internal solution was estimated by
calibration lines in the range used, either for the
radioactive or the fluorescent nucleotide. The bound
 .nucleotide B was estimated by the relationship:
L sL yLB I O
where: Ls ligand, Is in the bag, Osout of the
bag.
Aspecific binding was similarly estimated in paral-
lel experiments performed in the presence of 100 mM
cAMP: it was always less than 10% of specific
binding.
2.5. Fluorescence measurements
Fluorescence spectra were recorded with a Perkin
Elmer fluorescence spectrophotometer, thermostated
at Ts18"18C in NaCl 150 mM, phosphate buffer
20 mM pH 7.7, unless otherwise indicated. The
resolution of both monochromators was set at 5 nm.
Background fluorescence was estimated by spectra of
similar samples without fluorescent nucleotides. All
additions were made in small volumes, less than 3%
total volume. The data were corrected for dilution,
background fluorescence and instrument response.
Instrument correction factors were 0.635 at 480r508
nm and 0.530 at 510r540 nm.
 .Fluorescence anisotropy A was measured using
Polaroid polarizers and defined as:
As I y I r I q2 I .  .5 H 5 H
where I and I are the intensities observed parallel5 H
and perpendicular to the polarization of exciting light.
3. Results
3.1. Binding of fluorescent analogues to the cAMP
binding sites
As a first step, RI and RII subunits were tested for
w3 xH cAMP binding by the filtration assay. Half satu-
 .  .ration concentration nM was 50"8 ns3 for RI
 .and 68"12 ns3 for RII subunit. It was next
tested whether the fluorescent analogues SAF-cAMP
and SAR-cAMP competed with cAMP for binding.
w3 xInhibition of H cAMP binding in the presence of
fluorescent analogues is shown in Fig. 1. First ap-
 .proximation inhibition constant K rnM for SAF-i
cAMP was 120 and 170 for RI and RII subunits,
respectively, for SAR-cAMP was 28 and 35, and for
unlabelled cAMP 60 and 75, respectively. Finally
SAF-cAMP binding to RI and RII subunits was
w3 x  .Fig. 1. H cAMP displacement curve. A SAF-cAMP effect.
Filled squares: RI subunit; empty squares: RII subunit.
w3 x  . w3 xH cAMPs20 nM. R subunits1 nM. B H cAMP displace-
ment curve by SAR-cAMP. Empty squares: RII. Filled squares:
w3 xRI. H cAMPs20 nM. R subunits1 nM.
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Fig. 2. Fluorescence spectra of SAF-cAMP. Dotted line: SAF-cAMP 100 nM and RII 500 nM; continuous line: SAF-cAMP 100 nM
 .  .alone. A.U.: arbitrary fluorescence unit. A Excitation spectrum 420–504 nm; emission 508 nm; B excitation spectrum 430–526 nm,
 .  .  .emission 540 nm; C emission spectrum 500–580 nm, excitation 480 nm; D emission spectrum 516–580 nm, excitation 510 nm; E
 .emission spectrum 480–580 nm, excitation 325 nm, note the change in arbitrary unit scale; F emission spectrum 480–580 nm,
excitation 375 nm.
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Table 1
Ratio between fluorescence intensities at 480r508 and 510r540 in samples of free nucleotide alone and with added RI or RII at 188C
ExrEm l SAF-cAMP RII-SAF-caMP ControlrRII ratio RI-SAF-cAMP ControlrRI ratio
 .  .  .control A.U. A.U. A.U.
480r508 216 106 2.04 118 1.83
510r540 53.7 94.5 0.57 87 0.61
l intensity ratio 4.02 1.12 3.58 1.35 3
 .  .Fluorescence intensity arbitrary fluorescence units, A.U. at different excitationr emission wavelengths 480r508 nm and 510r540 nm
of free SAF-cAMP and SAF-cAMP in the presence of RII or RI. SAF-cAMPs100 nM, RI or RII 500 nM.
determined in a solution equilibrated by dialysis. The
 .binding capacity at 1.2 mM free nucleotide was
 .1.75"0.20 and 1.70"0.14 ns4 fluorescent ana-
logues for RI and RII, respectively. It was similar to
w3 x that for H cAMP 1.84"0.11 and 1.81"0.16,
.ns4 .
3.2. Fluorescence spectra
Spectra of the free fluorescent nucleotide was simi-
lar to that of the free fluorophore at pH 7.7, excita-
tion maximum 494 nm, emission maximum 518 nm
.for SAF-cAMP, 550 nm and 575 nm for SAR-cAMP .
Upon addition of regulatory subunits of cAMP de-
pendent kinases to a solution of SAF-cAMP, changes
both in the excitation and emission spectra were
detected. In order to better visualize these differ-
ences, fluorescence spectra were measured at differ-
ent excitation and emission wavelengths. By record-
 .ing emission at 508 nm Fig. 2A , an apparent de-
crease in the amplitude of the excitation spectrum
was observed, compared to the free SAF-cAMP. By
 .recording emission at 540 nm Fig. 2B , a red shift in
the excitation spectrum appeared: the peak at 494 nm
 .typical of the free fluorescent nucleotide was still
present, but a shoulder at 500–510 nm appeared. By
comparison to the free nucleotide excitation spec-
trum, a differential spectrum was calculated with a
 .peak at 510 nm data not shown .
The emission spectrum was similarly affected by
the presence of kinase regulatory subunits: the peak
of the free nucleotide was at a shorter wavelength,
518 nm, while the bound nucleotide had a peak at
526 nm. When the excitation was at 480 nm, the
fluorescence of the free nucleotide spectrum was
higher, while, when excitation was at 510 nm, the
ratio between the emission spectra of free and bound
nucleotide was reversed, the bound nucleotide fluo-
 .rescence being definitively higher Fig. 2C and D .
Binding to the kinase affected the nucleotide fluo-
rescence spectrum also in the UV region, although
the fluorescence intensity was greatly reduced: exci-
 .tation in the UV for example at 325 or 375 nm ,
highlighted differences in the visible region of the
emission spectra of free or bound nucleotide Fig. 2E
.and F . The excitation spectrum between 280–440
nm had a different shape when emission was recorded
at 508 nm in comparison to emission recorded at 540
nm, as expected by the emission spectra data not
.shown .
Spectral changes correlated with large fluorescence
intensity differences. These were more evident when
the ratio between fluorescence intensities measured at
different excitationremission wavelengths 480r508
.nm and 510r540 nm was considered, as shown in
Table 1, at 188C. These spectral differences were
sligthly reduced at 378C, Table 2, while were not
affected by pH in the range 7–7.7, except for an
Table 2
Ratio between fluorescence intensities at 480r508 and 510r540 in samples of free nucleotide alone and with added RI or RII at 378C
ExrEm l SAF-cAMP RII-SAF-cAMP ControlrRII ratio RI-SAF-cAMP ControlrRI ratio
 .  .  .control A.U. A.U. A.U.
480r508 209 108 1.93 115 1.83
510r540 66 92 0.72 77 0.85
l intensity ratio 3.16 1.17 2.7 1.49 2.12
Same conditions as Table 1.
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 .apparently uniform decrease 10% in fluorescence
intensity. No effect was observed when substituting
NaCl 150 mM with KCl 150 mM, when adding
CaCl 1 mM or changing Phosphate buffer from 3 to2
20 mM.
These fluorescence intensity differences, as well as
the spectral changes, were fully reversible upon addi-
 .tion of increasing cAMP concentrations Fig. 3 .
Fluorescence of bound nucleotides was quenched
by KI in solution. The KI concentrations needed for
the same extent of quenching were 1.5 higher as
 .compared to free SAF-cAMP data not shown . These
results indicate that the fluorophore of the bound
nucleotide was partially screened from energy dissi-
pative collisions with Iy. No change in the shape of
the fluorescence spectra of the bound nucleotide was
observed in the presence of KI.
Similar spectral changes, although of lesser ampli-
tude, were observed also for SAR-cAMP upon addi-
tion of kinases: a small red shift in the excitation
 .data not shown and emission spectra was observed
 .Fig. 4A and B ; to a limited extent, the fluorescence
intensity ratio of the control and kinase sample de-
pended on the wavelength considered. In the UV part
of the excitation spectra, spectral changes were barely
 .detectable data not shown .
3.3. Fluorescence anisotropy measurements
Addition of kinases to a SAF-cAMP solution
caused a large increase in anisotropy. The anisotropy
Fig. 3. Fluorescence intensity changes of bound nucleotide. In-
hibitory effect of increasing concentration of cAMP on fluores-
cence intesities ratio at 480r508 nm and at 510r540 nm. SAF-
cAMP 100 nM, RII 600 nM.
Fig. 4. Fluorescence spectra of SAR-cAMP. Dotted line: SAR-
cAMP 100 nM; RII 500 nM. Continuous line: SAR-cAMP 100
 .nM alone. A Emission spectrum 558–605 nm, excitation 550
 .nm; B emission spectrum 575–605 nm, excitation 570 nm.
values were different at different wavelengths: the
signal was larger at 510r540 nm wavelength couple
 .rather than at 480r508 nm Fig. 5A and B while the
anisotropy of the free nucleotide was not affected by
the wavelength in physiological solution As0.014
"0.002 at 480r508 nm, As0.018"0.005 at
.510r540 nm or at increasing solution viscosities.
Anisotropy of bound nucleotides can be estimated
w xby 1rA vs. 1r R plot. At 188C values at 480r508
nm were 0.195 and 0.210 for RI and RII, respec-
tively; at 510r540 nm values were 0.240 and 0.255
for RI and RII, at 378C values at 480r508 nm were
0.162 and 0.174 for RI and RII, at 510r540 nm
0.206 and 0.211, respectively.
( )C. Mucignat-Caretta, . CarettarBiochimica et Biophysica Acta 1357 1997 81–90 87
 .Fig. 5. SAF-cAMP fluorescence anisotropy measurements. A
Fluorescence anisotropy of SAF-cAMP upon addition of increas-
ing concentration of RI. SAF-cAMP 100 nM. NaCl 150 mM,
phosphate buffer 20 mM, pH 7.7, 188C. Filled squares: excitation
480 nmremission 508 nm; empty squares: excitation 510 nmr
 .emission 540 nm. B Fluorescence anisotropy of SAF-cAMP
upon addition of increasing concentration of RII. Same condi-
 .tions as in A . Filled squares: excitation 480 nmremission 508
nm; empty squares: excitation 510 nmr emission 540 nm.
A confirmatory measurement of anisotropy of the
bound nucleotide was obtained by equilibrium dialy-
sis. If it is assumed that the free nucleotide is equal to
the external concentration, the ratio between free and
bound nucleotide in the internal solution is directly
known, so the anisotropy values can be corrected for
the contribution of the free nucleotide. Anisotropy of
 .the bound nucleotide A can be estimated by:b
A s A yA r F yA .  .b s f b f
where A is the anisotropy of the sample, A iss f
the anisotropy of the free nucleotide and F is theb
fraction of bound nucleotide.
At 480r508 nm, A s0.194 and 0.205 for RI andb
RII, respectively, at 510r540 nm A s0.245 andb
0.258 for RI and RII, Ts188C.
Fluorescence anisotropy of the bound nucleotide
showed different characteristics at the different wave-
lengths examined: by increasing concentrations of
unlabelled cAMP, anisotropy was decreased more
effectively at 480r508 nm rather than at 510r540
 .nm Fig. 6A . The wavelength dependent difference
was still more apparent upon addition of cIMP, a
cyclic nucleotide reported to have a relatively higher
w xaffinity for the fast dissociating binding site 15 : the
anisotropy decrease, which presumably reflects
SAF-cAMP displacement, was steeper at 480r508
 .nm than at 510r540 nm wavelengths Fig. 6B .
Moreover, kinetics of anisotropy changes were differ-
ent at the different wavelengths used: upon addition
.Fig. 6. A Effects of unlabelled cAMP on bound SAF-cAMP
anisotropy. Inhibitory effect of increasing concentration of cAMP
on fluorescence anisotropy of SAF-cAMP bound to RII at
 .  .510r540 nm empty squares , and at 480r508 nm filled squares .
 .SAF-cAMPs100 nM, RIIs500 nM. A Before addition of
cAMP, fluorescence anisotropy at 510r540 nms0.242, and
anisotropy at 480r508 nms0.189. Measurements were made 2
 .h after addition of cAMP at every point. B Effect of increasing
concentration of cIMP on fluorescence anisotropy of SAF-cAMP
 .bound to RII at 510r540 nm empty squares , and at 480r508
 .  .nm filled squares . Same conditions as in A .
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of RII at 08C, a slower anisotropy increase was
observed at 480r508 nm, compared to 510r540 nm
 .Fig. 7A . Similarly, a large difference in kinetics of
anisotropy decrease was observed upon addition of
 .unlabelled cAMP 500 mM : at 08C, a very slow and
small decrease was observed at 510r540 nm, in part
presumably related to the larger anisotropy decrease
 .at 480r508 nm Fig. 7B . Only at higher temperature
a large anisotropy decrease was observed at 510r540
 .nm Fig. 7C .
Upon addition of kinases, a large anisotropy in-
 .crease was observed also for SAR-cAMP Fig. 8A .
The effects of different emission and excitation wave-
 .Fig. 8. SAR-cAMP fluorescence anisotropy measurements. A
Fluorescence anisotropy of SAR-cAMP upon addition of increas-
ing concentration of RI. SAR-cAMP 100 nM. NaCl 150 mM,
phosphate buffer 20 mM, pH 7.7, 188C. Filled squares: excitation
550 nm, emission 575 nm, empty squares: excitation 575
 . w xnmremission 595 nm. B 1r A vs. 1r RI plot, same data as in
Fig. 8A. Filled squares: excitation 550 nm, emission 575 nm,
empty squares: excitation 575 nmremission 595 nm.
Fig. 7. Time course of fluoresence anisotropy changes at T s08C.
 .A Kinetics of anisotropy increase at different wavelength upon
addition of RII at 08C. Data are presented as percentages of the
fluorescence anisotropy equilibrium values at 24 h: 0.192 at
480r508 nm, and 0.255 at 510r540 nm. SAF-cAMPs100 nM,
RIIs350 nM. Filled squares: 480r508 nm, empty squares:
510r540 nm. 75% of the equilibrium value was reached in 16
min at 510r540 nm and in 70 min at 480r508 nm. At T s188C,
fluorescence anisotropy values of a similar sample were 0.208 at
 .510r540 nm and 0.155 at 480r508 nm. B Time course of
fluorescence anisotropy decrease at 480r508 nm and at 510r540
nm after addition of cAMP 500 mM at 08C. Same conditions as
 .in A . Filled squares: 480r508 nm, empty squares: 510r540
 .nm. C Time course of fluorescence anisotropy decrease upon
 .  .addition of cAMP 500 mM at 348C. Same sample as in B .
Sample temperature was raised from 08C to 348C in 3 min. In the
absence of unlabelled cAMP, this temperature change decreased
by itself fluorescence anisotropy from 0.255 to 0.175 at 510r540
nm in a similar sample. Filled squares: 480r508 nm, empty
squares: 510r540 nm.
( )C. Mucignat-Caretta, . CarettarBiochimica et Biophysica Acta 1357 1997 81–90 89
lengths were smaller than for SAF-cAMP. The steeper
increase of anisotropy, dependent on increasing con-
centration of kinases, suggests an higher affinity for
the binding sites than SAF-cAMP. The anisotropy
increase was reversible upon addition of unlabelled
cAMP, but at a still slower rate than for SAF-cAMP
 .data not shown . The anisotropy values of the bound
nucleotide were 0.257 and 0.279, respectively, for RI
and RII at 550r575 nm, and 0.287 and 0.305 for RI
and RII, respectively, at 565r595 nm, as calculated
w x  .by 1rA vs. 1r R plot Fig. 8B .
4. Discussion
The data show that the fluorescent nucleotides
SAF-cAMP and SAR-cAMP bind to cAMP binding
sites of RI and RII with an affinity which compares
to cAMP. SAR-cAMP has the higher affinity, pre-
sumably because of the more hydrophobic nature of
the fluorophore.
Complex changes of fluorescence spectra and fluo-
rescence anisotropy are observed in bound fluores-
cent nucleotides. The excitation spectrum of SAF-
cAMP is peculiar: it presents a peak at 494 nm, as the
free nucleotide, and a shoulder at 510 nm, when
 .recording emission at 540 nm Fig. 2B . Anisotropy
values are dependent on the wavelength considered:
at 480r508 nm anisotropy is always lower than at
510r540 nm. Although the free nucleotide is more
effectively detected at 480r508 nm than at the longer
wavelengths, the anisotropy values are still different
when calculated by extrapolation at infinite binding
sites concentration or corrected for the contribution
of the free nucleotide, measured by equilibrium dialy-
sis.
These data are hardly explained assuming only one
binding reaction. On regulatory subunits however,
two different cAMP binding sites have been de-
scribed, type A or fast dissociating site and type B or
w xslow dissociating site 16 . The data are best under-
stood assuming two binding reactions of the fluores-
cent nucleotides.
In agreement with this hypothesis, cIMP decreases
more effectively anisotropy at 480r508 nm rather
than at 510r540 nm, so it is likely that the 510r540
nm fluorescence anisotropy reflects SAF-cAMP bind-
 w x.ing to the slow dissociating site site B, 15 while
the 480r508 fluorescence depends on binding to the
 .fast dissociating site site A .
Furthermore, kinetics of anisotropy changes Fig.
.7 , presumably reflecting nucleotide association and
dissociation, show that at 510r540 nm a binding
process with a higher affinity than at 480r508 nm is
measured. The dissociation kinetics monitored by
anisotropy at 510r540 nm at 08C is very slow,
w xcomparable to that reported for site B 17 at the
same temperature.
It may thus be suggested that SAF-cAMP has
different affinity for the two binding sites: as most
C8 substituted nucleotides, it shows a relative selec-
w xtivity for site B versus site A 14,18,19 .
The fluorescence anisotropy values of the bound
nucleotide are much higher than those reported for
w xother fluorescent nucleotides 20 , similar to a cova-
w xlently bound fluorophore 21 . An exact comparison,
however, is not possible because of the different
fluorescence lifetimes: 20 ns for etheno derivatives
w x22 and 4 ns for fluorescein derivatives.
The chemical basis of the red shift in the spectrum
is not obvious. Changes in the fluorescein absorption
spectra have been previously reported in relation to
w xthe polarity of the solvent 23 : hydrophobic interac-
tions are assumed to play an important role in cAMP
w xbinding 24,25 , and hydrophobic amino acids are
present in the cAMP binding sites of kinases and
around them. It is therefore likely that the fluo-
rophore of the nucleotide bound to one of the two
 .binding sites presumably site B , although still ac-
cessible to Iy quenching, is in a more hydrophobic
environment than the free nucleotide or that bound to
site A. Characterization of the amino acids responsi-
ble for this effect is not straigthforward, since the
fluorophore, because of its large size, may interact
with amino acids far from the binding site.
The extent of fluorescein quenching upon SAF-
cAMP binding to kinase is negligible. This observa-
tion is at variance to previous reports: large fluores-
cein quenching has been often observed upon binding
 w x.to proteins for example 21 ; similarly, binding of
etheno-cAMP a short wavelength fluorescent nu-
.cleotide is followed by a large fluorescence quench-
w xing 20,26–28 . These effects have been attributed to
interaction with tryptophan. In the present experi-
ments, no evidence of interaction between the fluoro-
phores of the bound nucleotides and tryptophan has
( )C. Mucignat-Caretta, . CarettarBiochimica et Biophysica Acta 1357 1997 81–9090
been observed, as indicated by tryptophan fluores-
 .cence spectra or energy transfer data not shown .
The fluorescent nucleotides may be useful tools in
cell research. They are stable and resistant to degra-
dation. Their fluorescence is free from interference
from endogenous fluorescence, because of the long
fluorescence excitation and emission wavelengths.
Because of the high quantum yield of the fluoro-
phores and of the high affinity for the kinase binding
site, they can be used at low concentration to detect
localization of concentrated cyclic nucleotide binding
w xsites 11,12 . They provide more informative images
than radioactive compounds, because of a better spa-
tial resolution, or available antibodies, which are
reported to have low affinity. Hopefully, if they are
injected inside a cell, the high anisotropy value of the
bound nucleotide might permit the detection of solu-
ble cAMP binding sites by fluorescence polarization
w xmicroscopy 29 . The spectral changes and conse-
quent changes in fluorescence intensity ratio at differ-
ent wavelenghts between free and bound nucleotide
may provide an indirect measurement of intracellular
cAMP activity in living cells, in addition to other
w xmethods already proposed 30 .
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